First Hawaiian Bank Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

First Hawaiian Bank cut its holdings in CVS Health Co. (NYSE:CVS) by 0.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,960 shares of the pharmacy operator’s stock after selling 368 shares during the quarter. First Hawaiian Bank’s holdings in CVS Health were worth $4,442,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new position in CVS Health during the 3rd quarter valued at $31,000. Reston Wealth Management LLC bought a new position in CVS Health in the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health during the 3rd quarter valued at about $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Truist Financial decreased their price target on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research note on Monday. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. UBS Group increased their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Mizuho lowered their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Stock Performance

Shares of CVS traded up $0.14 during trading hours on Wednesday, hitting $45.92. The stock had a trading volume of 12,573,443 shares, compared to its average volume of 12,420,939. The firm has a market capitalization of $57.79 billion, a PE ratio of 11.65, a PEG ratio of 0.85 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock has a fifty day moving average price of $52.40 and a 200 day moving average price of $56.86. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $81.03.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the firm posted $2.21 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. Analysts anticipate that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.79%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.